共 42 条
[1]
Abduvaliev A., Saydalieva M., Hidirova M., Gildieva M., Mathematical modeling of the thyroid regulatory mechanisms, Am J Med Sci Med, 3, 3, pp. 28-32, (2015)
[2]
Barbolosi D., Ciccolini J., Lacarelle B., Barlesi F., Andre N., Computational oncology–mathematical modelling of drug regimens for precision medicine, Nat Rev Clin Oncol, 13, pp. 242-254, (2016)
[3]
Barbolosi D., Summer I., Meille C., Serre R., Kelly A., Zerdoud S., Bournaud C., Schvartz C., Toubeau M., Toubert M.E., Keller I., Taieb D., Modeling therapeutic response to radioiodine in metastatic thyroid cancer: a proof-of-concept study for individualized medicine, Oncotarget, 8, 24, pp. 39167-39176, (2017)
[4]
Bonnema S.J., Hegedus L., Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome, Endocr Rev, 33, 6, pp. 920-980, (2012)
[5]
Boyce W.E., DiPrima R., Elementary differential equations and boundary value problems, (2012)
[6]
Carneiro M.L.B., Lopes C.A.P., Miranda-Vilela A.L., Joanitti G.A., Silva I.C.R., Mortari M.R., Souza A.R., Bao B.N., Acute and subchronic toxicity of the antitumor agent rhodium (ii) citrate in Balb/c mice after intraperitoneal administration, Toxicol Rep, 2, pp. 1086-1100, (2015)
[7]
Carvalho D.P., Ferreira A.C.F., The importance of sodium/iodide symporter (NIS) for thyroid cancer management, Arq Bras Endocrinol Metab, 51, 5, pp. 672-682, (2007)
[8]
Chen C.Y., Chang P.J., Changlai S.P., Pan L.K., Effective half life of iodine for five thyroidectomy patients using an in vivo gamma gamera approach, J Radiat Res, 48, 6, pp. 485-493, (2007)
[9]
Danziger L., Elmergreen G.L., The thyroid-pituitary homeostatic mechanism, Springer, 18, 1, pp. 1-13, (1956)
[10]
Degon M., Chipkin S.R., Hollot C.V., Zoeller R.T., Chait Y., A computational model of the human thyroid, Math Biosci, 212, pp. 22-53, (2008)